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Abstract 
Pigs are considered to be the main amplifying host for Japanese encephalitis virus (JEV), and their infection can cor‑
relate with human cases of disease. Despite their importance in the ecology of the virus as it relates to human cases 
of encephalitis, the pathogenesis of JEV in pigs remains obscure. In the present study, the localization and kinetics 
of virus replication were investigated in various tissues after experimental intravenous infection of pigs. The data 
demonstrate a rapid and broad spreading of the virus to the central nervous system (CNS) and various other organs. 
A particular tropism of JEV in pigs not only to the CNS but also for secondary lymphoid tissue, in particular the tonsils 
with the overall highest viral loads, was observed. In this organ, even 11 days post infection, the latest time point of 
the experiment, no apparent decrease in viral RNA loads and live virus was found despite the presence of a neutral‑
izing antibody response. This was also well beyond the clinical and viremic phase. These results are of significance for 
the pathogenesis of JEV, and call for further experimental studies focusing on the cellular source and duration of virus 
replication in pigs.
© 2016 Ricklin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Japanese encephalitis virus (JEV) causes an important 
zoonotic, vector-borne disease present in East Asia, 
Southeast Asia and Australasia [1, 2]. During JEV epi-
demics, human infections are widespread but only 0.1–
4% of infected individuals develop clinically apparent 
encephalitis. In the past, the annual incidence of such 
human cases was in the range from 50  000 to 175  000 
[1–3]. Importantly, the mortality of encephalitis cases is 
as high as 25–30%, and approximately 50% of the sur-
viving patients suffer from neuro-psychiatric sequelae 
[1, 2]. Therefore, JEV is considered to be the most fre-
quent viral encephalitis associated with fatal outcomes 
[4]. JEV is currently endemic in large parts of Southeast 
Asia but similar to other emerging diseases, globaliza-
tion and climate changes may result in virus emergence 
in the Western hemisphere. This would cause significant 
health problems in both the naïve human and animal 
population. During the last two decades West Nile virus 
as well as Usutu virus, which both belong to the JEV sero-
complex, emerged in Europe, demonstrating that related 
mosquito-born flaviviruses can spread to and remain 
in temperate regions [5]. Furthermore, the temperate 
northern Island of Japan Hokkaido, was affected by JEV 
epidemics and the virus was shown to overwinter and re-
emerge in the same local region [6].
The ecology of JEV includes a bird-associated wildlife 
cycle between Culex mosquitoes as vectors and mostly 
water birds such as egrets and herons as reservoirs. 
However, it appears that a high level of JE incidence in 
humans is associated with the presence of pigs as ampli-
fying hosts [1, 2]. Already early studies in the 1950s have 
demonstrated that pigs are readily infected and develop 
high level of viremia for several days [7–9]. This fact is 
an important feature of a pig-associated rural cycle, pre-
sent mostly in areas with intense pig farming and rice 
fields, which have been associated with frequent human 
JE cases [10].
While clinical symptoms in pigs are mild, humans and 
horses develop severe disease, and are considered as dead 
end hosts in which viremia is insufficient to infect feed-
ing mosquitos [1]. High seroprevalence in many other 
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vertebrates, such as dogs, chickens, ducks and reptiles 
indicate widespread infection by the virus but their role 
in the ecology of the virus is unclear [1]. Certainly, the 
high propensity of Culex tritaeniorhynchus to feed on 
pigs and the high birth rate with rapid turnover of the pig 
population favor the hypothesis of the pig as being the 
main amplifying host for JEV leading to human JE cases 
[1, 2].
During natural infection of pigs in JEV endemic areas, 
a viremic phase lasting 2–4 days has been described [7, 9, 
11]. Clinically, JEV field infections have been associated 
with increased rates of stillbirth and abortion [6, 12, 13]. 
Experimental infection of pigs resulted in development 
of transient fever and depression associated with a non-
suppurative encephalitis with viral antigen distributed 
broadly within the central nervous system (CNS) [14, 15].
Despite this information, the pathogenesis of JEV in 
pigs remains obscure. Specifically, the localization and 
kinetics of virus replication associated with viremia have 
not been studied. Furthermore, data of pig breeds kept 
in Europe such as Landrace, Large White or Duroc are 
lacking. The present study demonstrates that after exper-
imental infection of pigs JEV has a strong tropism not 
only to the CNS but also for secondary lymphoid tissue, 
in particular the tonsils.
Materials and methods
Animal experiment
All animal experiments were performed at biosafety level 
3 conditions (BSL3), and under the guidance of the Swiss 
animal welfare law, approved by the Cantonal ethical 
committee for animal experiments (BE 118-13). Twelve 
healthy seven-weeks old swiss large white pigs (seven cas-
trated males and five females) from our specific-patho-
gen-free (SPF)-breeding facility were used. Animals were 
housed in groups of  ≥3 inside the containment facility 
of the Institute for Virology and Immunology (IVI) rep-
resenting a BSL3-Ag facility. Prior to the inoculation 
experiment, they were allowed 1  week of adaptation to 
the new environment. After puncturing the jugular vein 
for a null blood sample all 12 animals were infected with 
107 TCID50 of JEV (Nakayama strain, obtained from the 
National collection of pathogenic viruses, NCPV, Salis-
bury, UK) in a volume of 2 mL, giving one half of the dose 
intravenously and the other half intradermally in the neck 
region. The Nakayama strain represents human genotype 
III isolate. It was used after two passages on Vero cells 
(ATCC, Manassas, VA, USA). Considering the low num-
ber of pigs possible for this study a high dose was chosen 
to ensure infection of all animals.
Animals were clinically examined daily, which included 
measuring body temperature and assessing aware-
ness, appetite, manure excretion, breathing, gait and 
neurological signs. Daily blood samples and oro-nasal 
swabs (Sarstedt, Nümbrecht, Germany) were collected 
from three animals until day 11. Swab samples were 
drenched in 500 µL medium and the stored at −70  °C 
until further processing.
To collect organ samples, groups of three pigs were 
euthanized by electroshock and subsequent exsanguina-
tion at days 3, 5, 7 and 11 post infection (pi). Sampling 
was performed immediately after exsanguination and 
included collection of blood (for serum and isolation of 
leukocytes) and organs for quantitative reverse tran-
scriptase polymerase chain reaction (qRT-PCR), virus 
isolation and histology. The following organs were sam-
pled: cervical lymph node, tonsils, spleen, ileum, bone 
marrow, thymus, kidney, liver, skeletal muscle and a 
peripheral nerve (nervus auriculopalpebralis) extracted 
from the neck region used for intradermal infection. 
The brain, spinal cord and spinal ganglia were taken out 
in toto. Of the CNS, the following parts were collected: 
cervical and sacral spinal cord, brain stem, cerebellum, 
thalamus, hippocampus, basal nuclei, neocortex fronta-
lis and temporalis, bulbus olfactorius, the meninges and 
choroid plexus. For histology organ samples were fixed 
in 4% buffered formalin for 3  days or 4  weeks for brain 
tissue. Peripheral blood mononuclear cells (PBMC) were 
isolated by density gradient centrifugation as previously 
described [16].
Virological analyses
Organ samples were taken into 1.5  mL tubes (Sarstedt) 
containing 500  µL MEM medium (Gibco, Life Tech-
nologies, Zug, Switzerland) and were weighed before 
homogenizing with a BulletBlender® (Next Advanced 
Inc. Averill Park, NY, USA). Homogenized organs were 
centrifuged and the supernatant transferred into a new 
tube to freeze immediately at −70  °C. For qRT-PCR, 
the samples were thawed and spiked with EGFP RNA as 
internal control prepared as described [17], and RNA was 
extracted using the QIAmp® viral RNA extraction kit 
(Qiagen AG, Hombrechtikon, Switzerland) according to 
manufacturer’s instructions. The real-time RT-PCR was 
performed as published previously [18], using the Super-
Script® III Platinum® One-Step qRT-PCR Kit (Life Tech-
nologies) and run on a 7900HT Thermocycler (Applied 
Biosystems) for 50 cycles. Results were used only if the 
EGFP RT-PCR showed a CT value <28 to assure quality 
of the RNA extraction and PCR reaction. To relatively 
quantify viral load, RNA obtained from a serially diluted 
stock of JEV Nakayama with a known titer was used as a 
standard. To this end, a virus stock with a known infectiv-
ity titer was serially diluted in log10 steps and viral RNA 
extracted. After qRT-PCR, CT values were determined 
to draw a standard curve, which was linear (correlation 
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coefficient R of 0.998) in the range of 35.6–12.6 CT which 
corresponded to 1  ×  100–1.2  ×  107 TCID50/mL of the 
viral stock. The CT value corresponding to 1 TCID50 was 
defined as 1 RNA unit (U). Using this standard, the CT 
values of our samples were then transformed into relative 
quantities as RNA U/mL. Organ samples were corrected 
for their weight and data calculated as relative RNA 
quantities/mg.
To determine infectious virus titers, samples were seri-
ally diluted in quadruplicates starting at a dilution of 1:2 
(if possible), and 100  μL was added to confluent Vero 
cells (ATCC, Manassas, VA, USA) cultured in 96-well 
plates with MEM medium (Life Technologies) contain-
ing 1% fetal bovine serum (FBS; Biochrome) and 0.01 M 
HEPES (Life Technologies). After 4 h, the inoculum was 
removed, replaced with fresh medium and the cells were 
incubated for 72 h before fixing them with 4% paraform-
aldehyde (Polysciences, Warrington, PA, USA) for 10 min 
and staining with the anti-flavivirus E protein monoclo-
nal antibody 4G2 (HB-112™ ATCC) in saponin (Sigma-
Aldrich Chemie GmbH, Buchs, Switzerland) followed 
by horseradish peroxidase conjugated rabbit anti-mouse 
antibody (Dako, Baar, Switzerland). The final color reac-
tion was obtained by adding 3-amino-9-ethylcarbazole 
(AEC) (Sigma-Aldrich). Titers were calculated using the 
Reed and Munch formula. The theoretical detection limit 
of the virus titration was around 5 TCID50/mL.
Histopathology
For histopathological evaluation organ samples and 
cross-sectioned blocks of representative areas of the CNS 
(medulla oblongata, pons, cerebellum, midbrain, thala-
mus, basal nuclei, olfactory bulb, hippocampus, cerebral 
cortex and spinal cord were embedded in paraffin, cut at 
4 µm and stained with hematoxylin and eosin (HE).
Lesions in the CNS were semi-quantitatively scored 
from 0 to 4 (0  =  no lesions, 1  =  minimal lesions, 
2  =  mild lesions, 3  =  moderate lesions, 4  =  severe 
lesions). The scores were based on the number of lesions, 
the type including perivascular cuffs, neuronal necrosis, 
glial nodules and parenchymal infiltration by inflamma-
tory cells, as well as size of lesions. Grade 1 was attrib-
uted to the presence of single thin perivascular cuffs 
only or focal small glial nodule. Grade 2 included few 
perivascular cuffs and few glial nodules. Grade 3 was 
characterized by prominent perivascular cuffs and multi-
ple dense glial nodules with clear neuronal degeneration 
and neuronophagia (as exemplified in Figure 4). Grade 4 
was characterized by extended lesions with prominent 
perivascular cuffs and numerous glial nodules, that may 
coalesce, and frequent evidence of neuronophagia. Three 
healthy, non-infected pigs from the IVI SPF facility were 
employed as negative controls.
Antibody responses
For plaque reduction neutralization tests (PRNT) sera 
were diluted in medium in triplicates starting at 1:5 and 
twofold serially diluted to a dilution of 1:640. One hun-
dred plaque forming units (PFU)/well of homologous 
virus were added to each well followed by gentle agitation 
and incubation at 37 °C for 30 min. Confluent Vero cells 
in flat bottom 96 well plates (Corning, Sigma Aldrich) 
were then incubated with 25 µL of the serum-virus mix 
for 1 h at 37 °C before washing with warm MEM medium 
(as above) and adding 200  µL of 1% methylcellulose 
(Sigma-Aldrich) medium supplemented with 100  IU 
penicillin and 100  µg/mL streptomycin at 200  µL/well. 
After incubation for 48  h at 37  °C, the cells were fixed 
and stained as described above. PRNT50 titres were read 
as the last serum dilution that showed a reduction of the 
counted PFU by 50%.
Cytokine ELISAs
Serum prepared from blood samples was analyzed for 
interferon-α (IFN-α), interleukin-1β (IL-1β), tumor 
necrosis factor-α (TNF-α) and interleukin-6 (IL-6) using 
commercial porcine cytokine ELISA kits (R&D Systems, 
Abingdon, UK) according to manufacturer’s instructions.
Statistical analysis
Statistical analysis was done with GraphPad Prism 
(GraphPad Software, La Jolla, USA) using ANOVA and 
Mann–Whitney U test to calculate group differences. 
Significance level was set at 5%.
Results
Clinical signs
Before experimental infection all 12 piglets were healthy 
and alert and had body temperatures of 38.7–38.9  °C. 
Already 24  h after infection all of them showed an 
increase in body temperature of up to 40.8 °C that lasted 
for 2–5  days before dropping to pre-infection levels 
(Figure  1A). Four pigs even reached body temperatures 
of above 41 °C. Fever curves were double peaked in most 
pigs. All animals showed reduced appetite, produced less 
manure and were reluctant to move for 3–6  days. With 
the normalization in body temperature also the clinical 
symptoms disappeared. However the three pigs kept until 
day 11 appeared to be depressed and showed a decreased 
appetite until day 9 pi.
Viremia
The three pigs sampled for blood daily showed a prom-
inent viremia in terms of viral RNA with a peak at day 
one pi and a viral RNA load of around 10  000 RNA U/
mL (Figure  1B). Based on a standard curve performed, 
one RNA U corresponds to 1 TCID50 infectious virus. 
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Viremia decreased gradually by 1–2 logs10 per day until 
day 4 pi. Sera from animals slaughtered on day 3 pi still 
showed a viremia above the threshold of the real-time 
RT-PCR with relative RNA quantities of 10 units/mL of 
serum. On day 5 all pigs were below cut-off of the RT-
PCR. To determine how viral RNA levels correlate to live 
virus detection by cell culture we titrated some of the 
sera. As shown in Figure1C, a comparable kinetic was 
found with three representative sera from the animals 
bled daily. In contrast to the serum, no viral RNA was 
detected in PBMC.
Oro‑nasal excretion of JEV
Interestingly, we were able to detect viral RNA and live 
virus in oro-nasal swabs collected from the three animals 
which were kept until day 11. As shown in Figure 1D, this 
was found between 2 and 8  days pi, depending on the 
animal.
Virus tropism for non‑CNS tissue
At day 3 pi (Figure  2A), all sampled organs includ-
ing lymph nodes, spleen, terminal ileum, bone marrow, 
thymus, kidney and liver were positive, mostly with 
viral RNA loads of 10–1000 RNA U/g. While the viral 
RNA load in the skeletal muscle was below 10 RNA 
U/g or negative, the tonsils contained 2–3 logs10 higher 
viral RNA loads reaching levels as high as 5 × 105 RNA 
U/g. At the later time points (Figures  2B–D) a gradual 
decrease of the viral loads in all organs, except the tonsils, 
was observed. Due to inevitable blood contamination 
some of the organs might have false positive viral loads, 
although in the peripheral blood only around 10 RNA 
U/mL were measured at 3 days pi. Interestingly, even at 
11  days pi (Figure  2D), there was no reduction in viral 
RNA loads in the tonsils. Also in the lymph node, spleen, 
terminal ileum (containing continuous Peyer’s patches in 
the pig), liver and kidney viral RNA was still found at day 
11 pi in some animals. The high levels of viral RNA in the 
tonsils were associated with detection of live virus in all 
tonsils obtained from infected pigs until 11 days pi with 
viral loads of up to 3 × 105 TCID50/g (Table 1). 
Virus tropism for CNS tissue
Even though no clinical neurological signs could be 
observed, most tested areas of the CNS contained viral 
RNA from day 3 to 7 pi (Figure 3). In some tissues such 
as thalamus, neocortex, basal nuclei a peak of viral RNA 
was observed at day 5 pi (Figure  3B). At day 11 pi, the 
end of the observational period, the CNS tissues of some 
animals did not contain detectable viral RNA anymore 
(Figure 3D). Peripheral nerve tissue, the spinal cord and 
meninges had relatively lower viral RNA levels, which 
decreased rapidly, whereas higher values were found in 
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Figure 1 Development of body temperature and viremia 
following experimental infection of pigs with JEV. 12 piglets 
were infected with 107 TCID50 JEV Nakayama strain. Pigs were killed in 
groups of three on days 3, 5, 7, and 11 pi. From three pigs daily serum 
samples were obtained, and from nine pigs blood samples were col‑
lected at necropsy (days 3, 5, 7 and 11 pi). A Daily body temperature 
of all animals. Each colour represents an individual animal. B Viral 
RNA loads in the serum. Relative JEV RNA quantities were determined 
using real‑time RT‑PCR. Quantification employed a standard curve 
created using a viral preparation with a known infectious titre. One 
U was defined as the viral RNA quantity corresponding to 1 TCID50 of 
the virus preparation used as standard. C Viral titres in the serum of 
individual bled daily. The detection limit of the assay was 5 TCID50/mL 
(dotted line). D Viral RNA loads in the oro‑nasal swabs collected daily 
from three different animals. The red symbols represent samples from 
which live virus isolation succeeded.
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the basal nuclei and the neocortex (frontalis and tempo-
ralis). Meninges and the choroid plexus remained nega-
tive throughout the observation period.
Pathology
Macroscopically, in five of the 12 animals a slightly 
increased amount of abdominal fluid was present on days 
5 and 7. These five animals were those with the more 
severe clinical signs. No other apparent macroscopic 
alterations were observed in any of the 12 animals. In the 
non-CNS tissues no histological changes were observed 
except signs of immune activation in secondary lym-
phoid tissue, particularly in the tonsils. In contrast, in the 
brain typical lesions of a viral meningoencephalomyelitis 
were observed. Lesions were characterized by multifo-
cal lymphohistiocytic perivascular cuffs affecting mainly 
the grey matter and to a lesser degree the white matter, 
associated with the presence of glial nodules and evi-
dence of neuronal degeneration and necrosis (Figure 4). 
Frequently, few neutrophils were present in the areas of 
neuronal necrosis. Additionally, multifocal mild lym-
phohistiocytic meningitis was present. The severity of 
lesions varied between animals, anatomical regions and 
over time. Lesions were mildest at day 3 pi (Figure 5A). 
The olfactory bulb was the only brain region clearly 
affected at this time point. Here, the lesions reached a 
peak between day 3 and 5 pi, whereas in all other CNS 
regions the most severe lesions were observed at day 5 
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Figure 2 Viral RNA loads in the peripheral organs following experimental infection of pigs with JEV. At necropsy peripheral organs were 
sampled and the tissue homogenized before quantitative RT‑PCR was run. Relative RNA quantities are shown for each day (A–D) calculated in U/mL 
as explained in the legend of Figure 1 and Materials and methods. Bars indicate mean values of a group. To illustrate RT‑PCR negative samples they 
were plotted as 10−1 U/mL. *difference statistically significant (p < 0.05) when this organ is compared to all others for a particular time point pi.
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or 7 pi (Figures 5B and C). When the scores allocated to 
the different areas of the CNS were added for each indi-
vidual pig, the highest values were obtained at 5 days pi 
(Figure 5E). 
Immune responses
To determine if JEV induced an early systemic inflam-
matory response, serum obtained from the daily blood 
samples was analyzed by ELISA for IFN-α, IL-1β, IL-6 
and TNF-α. In none of the samples cytokines levels above 
those of non-infected healthy pigs were found (data not 
shown).
All infected pigs rapidly seroconverted in terms of 
developing neutralizing antibodies. Already at 3  days pi 
two pigs showed a PRNT50 titer of 10 against the homol-
ogous virus which was above the non-specific PRNT50 
Table 1 Virus isolation data from tonsils
a Theoretical sensitivity 5 × 101 TCID50/g.
Pig # Days pi Virus titrationa
(TCID50/g)
1 3 3.14 × 104
2 3 3.16 × 105
3 3 3.16 × 105
4 5 1.47 × 103
5 5 3.16 × 105
6 5 3.14 × 104
7 7 3.16 × 105
8 7 1.00 × 104
9 7 1.78 × 104
10 11 4.39 × 102
11 11 6.81 × 104
12 11 3.16 × 103
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Figure 3 Viral RNA loads in the nervous system following experimental infection of pigs with JEV. At necropsy nervous tissues were sam‑
pled and homogenized before quantitative RT‑PCR was run. Relative RNA quantities are shown for each day (A–D) calculated in U/mL. Bars indicate 
mean values of a group. To illustrate RT‑PCR negative samples they were plotted as 10−1 U/mL. *difference statistically significant (p < 0.05) when 
this organ is compared to all others for a particular time point pi.
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titer of ≤5 found before infection. At day 5 all animals 
clearly seroconverted with increasing titers at 7 and 
11 days pi (Figure 6).
Discussion
Within the last two decades several vector borne viral 
diseases have emerged in Europe [19, 20]. The observa-
tion that JEV RNA was found in Culex pipiens in Italy 
represents a warning, although this was only described in 
one study [21]. In terms of mosquito vectors Culex and 
Aedes species, which can potentially transmit JEV, are 
present in southern Europe up to the south of Switzer-
land [22]. Considering that some areas in Europe have 
intensive pig farming, introduction of JEV could poten-
tially result in severe health and socio-economical con-
sequences. Pigs are considered to be the main amplifying 
host and important reservoirs along with water birds. In 
order to estimate the risk of a potential emergence of JEV 
into the Western hemisphere, it is important to know if 
local breeds of pigs are susceptible to viral infection, and 
in particular if they develop a viremia to a duration and 
magnitude comparable to Asian breeds of pigs. Our study 
indicates that this is the case at least with Swiss Large 
White pigs. The clinical signs observed were compara-
ble to findings of previous reports with fever of between 
40 and 41  °C for 3–5 days, with highest body tempera-
tures beyond the end of the viremia. This was associated 
with decreased appetite, awareness and depression. The 
observed symptoms were possibly caused by the viral 
encephalitis and not by a virally induced systemic inflam-
mation [14, 15]. With our infection model, viremia lasted 
for 2–4 days with the peak at day 1 pi. This was compara-
ble to the study of Sasaki and colleagues in which the pigs 
were viremic from day 1 to 4 pi using mosquito bite and 
subcutaneous injection [23]. Other studies also found a 
viremia of 1–3  days duration occurring between day 1 
and 5 pi [24, 25].
As in none of the previously published studies viral 
loads in various tissues were determined, the viral tro-
pism of JEV in the CNS and non-CNS tissue of pigs 
required investigations. For this reason, we performed 
real-time RT-PCR in various tissues collected from seri-
ally slaughtered pigs. Our data indicate that in the bone 
marrow, thymus, kidney, liver and skeletal muscle, the 
virus is not present much longer than the viremia is last-
ing, although individual variations were observed. In 
contrast, in the brain, as well as in secondary lymphoid 
tissue including spleen, lymph node and in particular the 
tonsils virus was detectable clearly beyond the viremic 
phase. As for the ileum, which had comparable viral RNA 
loads to the lymph nodes, we collected the terminal part 
containing the continuous Peyer’s patches. We specu-
late that also in this organ the site of virus replication is 
in lymphoid tissue. Altogether, our data indicate that the 
virus has a relatively broad tissue tropism with a prefer-
ence for nervous and lymphoid tissues. Nevertheless, 
although PBMC can be infected in vitro [26, 27], PBMC 
isolated from infected animals remained negative in the 
RT-PCR throughout the experiment. Future in vitro and 
in vivo studies are now required to determine the cellular 
tropism of JEV in pigs. Especially lymphoid tissue will be 
of large interest.
Although clinical signs were mild and no clear neuro-
logical deficits were observed, all animals were affected 
by non-suppurative meningoencephalomyelitis. Lesions 
in most brain regions appeared at day 3 and persisted 
Figure 4 Neuropathology in the olfactory bulb of a JEV-infected pig at 5 days pi (score 3). A Histopathology of the olfactory bulb (bub) 
and tract (tract). Multifocal glial nodules were present in the grey matter of the olfactory bulb (arrows) and accompanied by mononuclear perivas‑
cular cuffs (arrowheads). H and E, 20× magnification, bar = 500 µm. B Higher magnification (400×) of one glial nodule shown in A). One degener‑
ated, shrunken neuron (arrow) in the olfactory bulb is surrounded by a nodule of microglial and inflammatory cells. H and E, bar = 20 µm.
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Figure 5 Histological scores in the CNS following JEV-infection of pigs. At necropsy brains and the spinal cord were sampled, fixed and 
processed routinely for H and E staining. Data are shown for each day (A–D) separately. Lesions were scored semi‑quantitatively from 0 to 4 (0=no 
lesions, 1=minimal lesions, 2=mild lesions, 3=moderate lesions, 4=severe lesions). Scores of three healthy control piglets (CTRL) were 0. E Sum of 
all CNS tissues scores with each symbol representing an individual pig.
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until day 11 pi. The spinal cord and cerebellum were 
affected from day 5 on. Lesions and their distribution 
were similar to JEV-meningoencephalomyleitis previ-
ously described in experimental intravenous infections 
of pigs and macaques [14, 15, 28] and in natural infec-
tions of human [29–31]. Similar to these studies, we 
found neuronal degeneration and necrosis confirm-
ing a neurotropism of the JEV strain used [14, 15, 28]. 
Although the olfactory bulb appeared to be slightly 
stronger affected than other CNS regions at day 3, the 
widely disseminated distribution of lesions was compat-
ible with a hematogenous virus entry into the CNS [14], 
possibly by free virus particles during the viremic phase 
as indicated by our serum RT-PCR results. The absence 
of JEV in PBMC indicate that these cells do not func-
tion as Trojan horses for JEV entry into the CNS as it has 
been described for other viruses [32, 33]. As described in 
mice JEV entry into the CNS via the blood-cerebrospinal 
fluid barrier appears to be unlikely as neither viral RNA 
or lesions were observed in the choroid plexus nor in 
ependymal or periventricular tissue [34]. Future studies 
also need to consider alternatives routes of viral entry 
into the CNS, such as transneural virus transport, which 
may occur for example from the olfactory nerve to the 
olfactory bulb from which the virus may further spread 
to the CNS as has been described for other neurotropic 
flaviviruses (for review see [35]). This may link virus rep-
lication in the tonsils with spread to the CNS.
The most striking novel observations in terms of JEV 
tropism were found in the tonsils, in which JEV appeared 
to continue its replication for at least 11 days. This was 6 
days after the end of viremia and the onset of neutraliz-
ing antibody responses. In addition, viral loads were 100–
1000 times higher compared to other organs. Only in one 
previous study, JEV was isolated from the tonsil of a pig 
[14] but to our knowledge, viral infection of the tonsils in 
pigs or other species has not been described. It should be 
noted that the present study employed a high dose of JEV 
(107 TCID50/animal), which could theoretically result in a 
different tissue distribution as a natural infection. How-
ever, although we do not have samples from naturally 
infected pigs available, data from several pigs infected 
with doses of JEV as low as 103 TCID50/animal via the 
oro-nasal route resulted in a comparable tissue distribu-
tion. Again, the highest viral loads are also found in the 
tonsils [36]. This suggests that although the kinetic of the 
infection and the incubation time may vary, the virus dis-
tribution reported here is relevant for the field situation.
Future studies are required to determine how long 
the virus can persist in pigs as a long-term persistence 
could have an important impact on the ecology of JEV in 
temperate regions. In fact, for recurrent JEV outbreaks 
observed in particular farms in consecutive years in Hok-
kaido, the mechanisms of hibernation of JEV remain 
unclear [6, 37]. Although experimentally JEV can trans-
mit vertically in Culex mosquitoes [38, 39], it has been 
very difficult to find infected mosquito larvae in the field 
[40].
Previous studies indicate that neutralizing antibodies 
are important for protection against JEV with a protec-
tive neutralizing titer of 10, in both humans and in pigs 
[25, 41–43]. Our study confirms that the immune sys-
tem of pigs efficiently and rapidly reacts to JEV infec-
tion. Within one weak pi, similar levels of neutralizing 
antibodies are reached as compared with a live attenu-
ated vaccine [23] conferring protective immunity. Under 
our experimental conditions JEV did not induce systemic 
inflammatory cytokine response also supporting a rapid 
control of virus replication.
Taken together this study demonstrates that after 
experimental infection of pigs JEV rapidly and broadly 
spreads to the CNS and various organs outside the CNS. 
It appears that the secondary lymphoid tissue plays a 
prominent role in virus replication with the tonsils being 
a predilection site for JEV in terms of both viral loads 
and duration of replication. Considering the important 
role of pigs in the ecology of JEV, future investigations 
are required to understand virus-host interactions at the 
level of the organism and the cell.
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